Research Advances in Blood Transfusion Medicine in the Year of 2022

doi:10.3969/j.issn.1671-2587.2023.03.023

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2023, Vol. 25 ›› Issue (3): 415-419.DOI: 10.3969/j.issn.1671-2587.2023.03.023

Previous Articles Next Articles

Research Advances in Blood Transfusion Medicine in the Year of 2022

HE Minwei, ZHAN Linsheng

Institute of Health Service and Transfusion Medicine, Beijing 100850

Received:2023-03-30 Published:2023-07-10

Abstract

Abstract: With the application of cutting-edge technologies such as bioomics, bioengineering and novel nanomaterials, our understanding of blood transfusion medicine is constantly improving year by year. Here, we reviewed representative research in the fields of blood generation/replacement, blood cell storage lesion, transfusion related adverse effect, clinical transfusion therapy and provided an insight into the advances of our knowledge in blood transfusion.

Key words: Blood transfusion, Cutting-edge advances, Review

CLC Number:

R457

HE Minwei, ZHAN Linsheng. Research Advances in Blood Transfusion Medicine in the Year of 2022[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 415-419.

References

[1] AN H H,GAGNE A L,MAGUIRE J A,et al.The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine[J]. Blood,2022,140(15):1723-1734.
[2] BTRU.RESTORE clinical trial[EB/OL].https://www.bristol.ac.uk/btru/work/trial.
[3] QIN J H,ZHANG J,JIANG J N,et al. Direct chemical reprogramming of human cord blood erythroblasts to induced megakaryocytes that produce platelets[J]. Cell Stem Cell,2022,29(8):1229-1245.e7.
[4] XIA L J.Engineered platelets for clinical application:a step closer[J]. Blood,2022,140(22):2314-2315.
[5] SUGIMOTO N,KANDA J Y,NAKAMURA S,et al.iPLAT1:the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study[J]. Blood,2022,140(22):2398-2402.
[6] AZUMA H,AMANO T,KAMIYAMA N,et al.First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative[J]. Blood Adv,2022,6(21):5711-5715.
[7] SUN K Q,ZHANG Y J,D'ALESSANDRO A,et al. Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia[J]. Nat Commun,2016,7:12086.
[8] HAY A,NEMKOV T,GAMBONI F,et al.Sphingosine 1-phosphate has a negative effect on RBC storage quality[J]. Blood Adv,2023,7(8):1379-1393.
[9] FAN X M,WANG Y,CAI X H,et al.CPT2 K79 acetylation regulates platelet life span[J]. Blood Adv,2022,6(17):4924-4935.
[10] RABCUKA J,BLONSKI S,MELI A,et al.Metabolic reprogramming under hypoxic storage preserves faster oxygen unloading from stored red blood cells[J]. Blood Adv,2022,6(18):5415-5428.
[11] DE BRUIN S,PETERS A L,WIJNBERGE M,et al.Storage of red blood cells in alkaline PAGGGM improves metabolism but has no effect on recovery after transfusion[J]. Blood Adv,2022,6(13):3899-3910.
[12] PANDEY S,MAHATO M,SRINATH P,et al.Intermittent scavenging of storage lesion from stored red blood cells by electrospun nanofibrous sheets enhances their quality and shelf-life[J]. Nat Commun,2022,13:7394.
[13] APTE G,BÖRKE J,ROTHE H,et al. Modulation of platelet-surface activation:current state and future perspectives[J]. ACS Appl Bio Mater,2020,3(9):5574-5589.
[14] APTE G,HIRTZ M,NGUYEN T H.FluidFM-based fabrication of nanopatterns:promising surfaces for platelet storage application[J]. ACS Appl Mater Interfaces,2022,14(21):24133-24143.
[15] SOLDATENKO A,HOYT L R,XU L,et al.Innate and adaptive immunity to transfused allogeneic RBCs in mice requires MyD88[J]. J Immunol,2022,208(4):991-997.
[16] QIU A N,MILLER A,ZOTTI F D,et al.FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization[J]. Front Immunol,2022,13:972723.
[17] WEBBER A M,BRADSTREET T R,WANG X L,et al.Antigen-guided depletion of anti-HLA antibody-producing cells by HLA-Fc fusion proteins[J]. Blood,2022,140(16):1803-1815.
[18] CABLE R G,GLYNN S A,KISS J E,et al.Iron deficiency in blood donors:the REDS-II Donor Iron Status Evaluation (RISE) study[J]. Transfusion,2012,52(4):702-711.
[19] Z SZCZEPIORKOWSKI, T HOPKINS. Updated strategies to limit or prevent iron deficiency in blood donors, Association bulletin #17-02[EB/OL].(2017-03-16).https://www.aabb.org/docs/default-source/default-document-library/resources/association-bulletins/ab17-02.pdf?sfvrsn=55d7caaf_4. 2017.
[20] HOD E A,BRITTENHAM G M,BITAN Z C,et al.A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being[J]. Blood,2022,140(25):2730-2739.
[21] BRUUN-RASMUSSEN P,KRAGH ANDERSEN P,BANASIK K,et al.Intervening on the storage time of RBC units and its effects on adverse recipient outcomes using real-world data[J]. Blood,2022,139(25):3647-3654.
[22] SAITO-BENZ M,BENNINGTON K,GRAY C L,et al.Effects of freshly irradiated vs irradiated and stored red blood cell transfusion on cerebral oxygenation in preterm infants[J]. JAMA Pediatr,2022,176(5):e220152.
[23] WHYTE R K.Neurodevelopmental outcome of extremely low-birth-weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion[J]. Semin Perinatol,2012,36(4):290-293.
[24] FRANZ A R,ENGEL C,BASSLER D,et al.Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants[J]. JAMA,2020,324(6):560.
[25] PATEL R M,LUKEMIRE J,SHENVI N,et al.Association of blood donor sex and age with outcomes in very low-birth-weight infants receiving blood transfusion[J]. JAMA Netw Open,2021,4(9):e2123942.
[26] ALSHALANI A,UHEL F,CREMER O L,et al.Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients[J]. Blood Adv,2022,6(11):3260-3267.

Research Advances in Blood Transfusion Medicine in the Year of 2022

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	GAO Zongshuai, ZHANG Haifang, LI Zhiqiang. Effect of Allogeneic Blood Transfusion on Plasma Exosomal MiRNA Expression in Patients with Traumatic Blood Loss [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 334-341.
[2]	LI Huan, XIE Jia, HE Hongwei, et al. Transfusion-related Respiratory Adverse Reactions in Patients with Massive Perioperative Blood Transfusion in Cardiac Surgery：A Retrospective Study [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 358-362.
[3]	LI Zhengfeng, WANG Jia, CHEN Ping, et al. A Cross-sectional Study on the Distribution and Influencing Factors of Unexpected Antibody Positive Results in Pediatric Hospitalized Patients Planning to Receive Blood Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 374-378.
[4]	DENG Gui-hua, LONG Xin-yan, SUN Ya-chun, et al. The Establishment of the Intelligent Blood Transfusion Medicine [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(2): 185-189.
[5]	FAN Feng-yan, MA Yue-yun. The Selection of RhD Blood Type in Blood Transfusion of RhD Mismatched Allogeneic Hematopoietic Stem Cell Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(2): 189-192.
[6]	CHENG Zhi-xiang, REN Lin, CAO Hong-rong, et al. Haemovigilance for Guideline-based Blood Transfusion Adverse Events [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 48-55.
[7]	LIU Zhi-xin, WU Xiao-shuang, MENG Wei-cheng, et al. A Mouse Model of Acute Hemolytic Transfusion Reactions [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 63-68.
[8]	WEN Pu-sheng, YANG Yuan-qi, PENG Xue-song, et al. Risk Factors of Massive Blood Transfusion in 140 Children with Living Donor Liver Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 97-102.
[9]	XIE Hui-yi, ZHOU Zai-xin, YANG Yue, et al. Analysis of the Influence of Anti-M Antibody on Blood Group Identification and Clinical Blood Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(6): 716-720.
[10]	SONG Qian, MA Yi-ran. Therapeutic Efficacy of Red Blood Cell Transfusions in Patients with Positive Crossmatching Test Caused by Autoantibodies [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(5): 588-590.
[11]	LI Zhi-qiang, LI Xing-long, LI Li-wei, et al. Mental Health Status of Blood Transfusion Practitioners in Medical Institutions [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(5): 605-609.
[12]	PAN Xue, SONG Ying-Wei, LIN Jie, et al. Effects of Preoperative Anemia on Perioperative Blood Transfusion and Clinical Outcomes in Patients Undergoing Orthopedic Surgery [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 409-415.
[13]	WANG Shuai, LI Jun. Analyze the Influencing Factors and Alloimmunization on Rh（CcEe）in Patients with Liver Cirrhosis after ABO, Rh（D） Isotype Random Matched Blood Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 443-447.
[14]	LI Yan-hui, SHI Lin-ying, ZHOU Mou, et al. Experimental Study on Core Performance Test of the Heating and Pressurizing Blood Transfusion Apparatus [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 448-454.
[15]	LI Jin-qi, ZANG yan, LI Jin-ying, et al. Blood Transfusion Therapy in Children with Hereditary Refractory Hemolytic Anemia：A Retrospective Analysis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 325-327.